Infliximab vs. Adalimumab in Crohn ' s Disease Infliximab vs. Adalimumab in Crohn ' s Disease
Do the anti-TNF agents infliximab and adalimumab have comparable response characteristics? Are concomitant immunomodulators necessary for optimal response?Alimentary Pharmacology & Therapeutics
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology Journal Article Source Type: news
More News: Allergy | Allergy & Immunology | Crohn's Disease | Drugs & Pharmacology | Gastroenterology | Humira | Inflammatory Bowel Disease | Remicade